PABA.

PABA is the aromatic building block bacteria incorporate into the pteroate ring of folate. Humans do not run that pathway, so PABA and dietary folate meet only through gut flora rather than through any shared human enzyme.

Several colonic bacteria assemble folate de novo and use PABA as the required aromatic precursor. Supplying both a folate-producing strain and its substrate is coherent at the level of microbial metabolism.

PABA has been a standing member of B-complex formulas since the 1940s, when it was classed with the B vitamins before its status was clarified. Riboflavin sits in the same tablet by that convention. This is formulation history, not a shared pathway in human cells.

Pantothenic acid and PABA appear together in the classic B-complex line-up and in the hair and skin formulas built on it. The pairing is a labelling convention carried forward from mid-century vitamin science. No metabolic dependency links them in people.

Biotin and PABA are co-formulated in hair and nail products almost as a rule. Biotin has a defined human enzymatic role as a carboxylase cofactor; PABA does not, and the pairing reflects marketing lineage rather than shared biochemistry. Stating that plainly is the honest version.

Inositol, choline and PABA form the trio of former B-complex members that were later reclassified as non-vitamins for humans. They still travel together in B-complex tablets. The grouping is historical.

Choline shares the same B-complex shelf position as PABA and unlike PABA does have an established human requirement. They are co-formulated by convention. No interaction between them is described.

Many gut bacteria build folate de novo from para-aminobenzoate through dihydropteroate synthase, an enzyme humans do not possess. PABA reaching the colon is therefore a substrate for bacterial folate synthesis, not for the host's own. Whether that changes host folate status is not established.

Lactobacillus species vary in whether they synthesise folate or scavenge it, and those that synthesise it condense para-aminobenzoate with a pterin intermediate. PABA is thus an input to microbial folate production. This is bacterial biochemistry and says nothing directly about human folate levels.

Tyrosinase, the enzyme that starts melanin synthesis, is a copper-dependent enzyme. PABA turns up in pigment-facing formulas, so copper is the nutrient with an actual established role in that pathway. Naming the cofactor is more useful than repeating the folklore around PABA and hair colour.

Melanin is built from tyrosine by way of DOPA and dopaquinone. Any pigment-facing formula that includes PABA is relying on tyrosine and copper for the part of the pathway that is actually characterised. PABA itself has no defined step in melanin synthesis.

Ascorbate is a common companion in topical and oral photoprotection formulas and works as an aqueous-phase antioxidant. PABA's photoprotective history is about direct UVB absorption, a physical filter effect, which is a different mechanism entirely. The two are complementary in a formula rather than interacting chemically.

Zinc appears alongside PABA in skin and hair formulas and has established roles in keratin structure and normal skin integrity. The pairing is a formulation habit with zinc carrying the characterised biology. No direct interaction between the two is described.